RIR
DCGO icon

Rayliant Investment Research’s DocGo DCGO Stock Holding History

Rayliant Investment Research’s Portfolio DCGO Stock Details DCGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$208K Buy
+25,980
New +$218K 3% 9

Other funds holding DCGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Rayliant Investment Research's DCGO Position: Q4 2022 in Review

Rayliant Investment Research opened a new position in DocGo (DCGO) in Q4 2022: 25,980 shares worth $208K. The stake represents 3% of the portfolio and ranks #9 among its holdings.

128 funds tracked by Wall St. Rank hold DCGO as of Q4 2022.

  • Rayliant Investment Research held 25,980 shares of DocGo worth $208K as of Q4 2022.
  • DocGo was a new Rayliant Investment Research position in Q4 2022.
  • DocGo made up 3% of Rayliant Investment Research's portfolio in Q4 2022, its #9 holding.
  • 128 funds tracked by Wall St. Rank held DocGo as of Q4 2022.

Based on Rayliant Investment Research's 13F filing for Q4 2022, filed 14 Feb 2023.